Alphageneron Announces Successful Completion of FDA Pre-IND Meeting of Proposed Phase II Clinical Trial for NK Cell Therapy with Advanced (stage III & Stage IV) NSCLC Patients
CAMBRIDGE, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”),…
QuestDB Supports HDFC Bank’s Real-Time Transaction Monitoring and Risk Analytics